4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Protocolo de autocuidado para pacientes con psoriasis desde la farmacia comunitaria Translated title: Self-care protocol for patients with psoriasis from community pharmacy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen Introducción: Debido a la baja calidad de vida y adherencia al tratamiento de los pacientes con psoriasis se plantea desarrollar un protocolo de empoderamiento que conduzca a un mayor conocimiento del autocuidado en pacientes con esta patología, acorde a sus necesidades, siendo importante el papel del farmacéutico para la mejora de ambos. Método: Se administró el test Morisky Green-4 items y el cuestionario Dermatology Life Quality Index a 40 pacientes con psoriasis que acudían a una farmacia comunitaria. Con estos datos, la información de las guías clínicas y la colaboración con un dermatólogo, se diseñó un protocolo de autocuidado. Resultados: Se observó falta de adherencia en el 100% de los pacientes y una calidad de vida leve/moderada (5,3±4,2), en las preguntas relacionadas con: los síntomas cutáneos afectan mucho/muy al 50% de los pacientes y la sensación de vergüenza y dificultad con su tratamiento entre poco y mucho en el 60%. Con estos resultados se diseñaron dos dípticos. A los 3 meses la calidad de vida mejoró a 3,98±2,05, p=0,048, y se observó falta de adherencia en el 70% de los pacientes. Conclusiones: Los protocolos de autocuidado son necesarios para mejorar la calidad de vida de los pacientes crónicos. El papel del farmacéutico es importante a través de un protocolo de autocuidado en pacientes con psoriasis, ayudando a mejorar la adherencia al tratamiento y la calidad de vida.

          Translated abstract

          Abstract Introduction: Due to the low quality of life and adherence to treatment of patients with psoriasis, it is proposed to develop an empowerment protocol that leads to greater knowledge of self-care in patients with this pathology, according to their needs, with the role of the pharmacist being important for the improvement of both. Method: The Morisky Green-4 items test and the Dermatology Life Quality Index questionnaire were administered to 40 patients with psoriasis who attended a community pharmacy. With these data, information from clinical guidelines and collaboration with a dermatologist, a self-care protocol was designed. Results: Lack of adherence was observed in 100% of the patients and a mild/moderate quality of life (5.3±4.2), in questions related to: skin symptoms affect a lot/very much 50% of the patients and feeling of embarrassment and difficulty with their treatment between a little and a lot in 60%. With these results, two diptychs were designed. Three months later, the quality of life improved to 3.98±2.05, p=0.048, and non-adherence was observed in 70% of the patients. Conclusions: Self-care protocols are necessary to improve quality of life of chronic patients. The role of the pharmacist is important through a self-care protocol in patients with psoriasis, helping to improve adherence to treatment and quality of life.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: not found
          • Article: not found

          Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Psoriasis: classical and emerging comorbidities*

            Psoriasis is a chronic inflammatory systemic disease. Evidence shows an association of psoriasis with arthritis, depression, inflammatory bowel disease and cardiovascular diseases. Recently, several other comorbid conditions have been proposed as related to the chronic inflammatory status of psoriasis. The understanding of these conditions and their treatments will certainly lead to better management of the disease. The present article aims to synthesize the knowledge in the literature about the classical and emerging comorbidities related to psoriasis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Burden of Inflammatory Bowel Disease in Europe in 2020

              New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are still increasing worldwide, and approximately 0.2% of the European population suffer from IBD at the present time. Medical therapy and disease management have evolved significantly in recent decades, with an emphasis on tight objective monitoring of disease progression and a treat-to-target approach in Europe and also worldwide, aiming to prevent early bowel damage and disability. Surgery rate declined over time in Europe, with 10–30% of CD and 5–10% of UC patients requiring a surgery within 5 years. The health economic burden associated with IBD is high in Europe. Direct health care costs [approximately €3500 in CD and €2000 in UC per patient per year] have shifted from hospitalisation and surgery towards drug-related expenditures with the increasing use of biologic therapy and other novel agents, and substantial indirect costs arise from work productivity loss [approximately €1900 per patient yearly]. The aim of this paper is to provide an updated review of the burden of IBD in Europe by discussing current data on epidemiology, disease course, risk for surgery, hospitalisation, and mortality and cancer risks, as well as the economic aspects, patient disability, and work impairment, by discussing the latest population-based studies from the region.
                Bookmark

                Author and article information

                Journal
                pharmcare
                Pharmaceutical Care España
                Pharm Care Esp.
                Fundación Pharmaceutical Care España (Barcelona, Barcelona, Spain )
                1139-6202
                2794-1140
                June 2023
                : 25
                : 3
                : 30-43
                Affiliations
                [1] Granada Andalucía orgnameUniversidad de Granada orgdiv1Facultad de Farmacia orgdiv2Sección de Farmacia Asistencial, Social y Legal. Departamento de Farmacia y Tecnología Farmacéutica Spain
                Article
                S2794-11402023000300004 S2794-1140(23)02500300004
                10.60103/phc.v25i3.805
                42e0b0bd-0199-4a86-b3a4-73e01d71a7ff

                This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

                History
                : 23 January 2023
                : 21 May 2023
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 31, Pages: 14
                Product

                SciELO Spain

                Categories
                Originales

                autocuidado,therapeutic adherence,quality of life,community pharmacy,psoriasis,Self-care,adherencia terapéutica,calidad de vida,farmacia comunitaria

                Comments

                Comment on this article